Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Expert Opinion on Biological Therapy|June 5, 2014
Bone marrow cell therapies in ischemic cardiomyopathyMarcin Wysoczynski, Kyung U Hong, Joseph B MooreStem Cells (Dayton, Ohio)|August 10, 2016
The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent MechanismJoseph B Moore, John Zhao, Matthew C L Keith, et al.Non-Coding RNA|July 16, 2020
Macrophage Long Non-Coding RNAs in Pathogenesis of Cardiovascular DiseaseMarcin Wysoczynski, Jae Kim, Joseph B Moore, et al.Plos One|October 17, 2015
C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK PathwaysBathri N Vajravelu, Kyung U Hong, Tareq Al-Maqtari, et al.Frontiers in Cardiovascular Medicine|July 18, 2022
Rigor Me This: What Are the Basic Criteria for a Rigorous, Transparent, and Reproducible Scientific Study?Brian E Sansbury, Matthew A Nystoriak, Shizuka Uchida, et al.Stem Cell Reviews and Reports|October 19, 2016
Inducible Nitric Oxide Synthase (iNOS) Is a Novel Negative Regulator of Hematopoietic Stem/Progenitor Cell TraffickingMateusz Adamiak, Ahmed Abdelbaset-Ismail, Joseph B Moore, et al.Journal of the American Heart Association|July 7, 2017
Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and SecretionJoseph B Moore, John Zhao, Annalara G Fischer, et al.European Heart Journal|November 29, 2019
A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repairMarcin Wysoczynski, Roberto BolliCell Transplantation|July 15, 2016
Downregulation of Heme Oxygenase 1 (HO-1) Activity in Hematopoietic Cells Enhances Their Engraftment After TransplantationMateusz Adamiak, Joseph B Moore, John Zhao, et al.Stem Cell Reviews and Reports|May 19, 2019
Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGFMarcin Wysoczynski, Asif Pathan, Joseph B Moore, et al.Pageof 13